Taylor Morrison Home (TMHC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 22, 2025, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote by May 21, 2025.
Voting matters and shareholder proposals
Election of nine directors is on the agenda, with board recommendations to vote for all nominees.
Advisory vote on executive compensation (say-on-pay) is included, with board recommending approval.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2025, is proposed.
Provision to transact other business as may properly come before the meeting.
Board of directors and corporate governance
Director nominees include Peter Lane, Anne L. Mariucci, David C. Merritt, Heather C. Ostis, Andrea Owen, Sheryl D. Palmer, Fletcher F. Previn, Denise F. Warren, and Christopher Yip.
Latest events from Taylor Morrison Home
- 2025 delivered strong earnings and margins; 2026 outlook expects margin recovery and robust capital returns.TMHC
Q4 202511 Feb 2026 - Q3 2025 saw $2.0B revenue, $201M net income, and 22.1% gross margin with strong liquidity.TMHC
Q3 20255 Feb 2026 - Targeting 20,000 closings by 2028 with digital innovation, margin focus, and brand expansion.TMHC
Investor Day 20253 Feb 2026 - Q2 2024 delivered 3,200 closings, $1.99B revenue, and raised full-year guidance.TMHC
Q2 20243 Feb 2026 - Q3 net income up 54% to $251M, with record revenue, margin gains, and strong outlook.TMHC
Q3 202419 Jan 2026 - Double-digit growth in closings and revenue, with strong margins and 2025 outlook.TMHC
Q4 202411 Dec 2025 - Board recommends approval of all proposals, emphasizing governance, pay-for-performance, and ESG.TMHC
Proxy Filing1 Dec 2025 - Q1 2025 delivered 12% revenue growth, margin expansion, and strong liquidity.TMHC
Q1 202529 Nov 2025 - Q2 2025: 3,340 homes, $2.0B+ revenue, 23% margin, net sales orders down 12%, strong liquidity.TMHC
Q2 202530 Oct 2025